Stem Cell Treatment for Asthma
Regenerative Relief: Stem Cell Treatment for Asthma
Asthma is a chronic inflammatory condition that affects the airways and limits respiratory function. Stem cell treatment for asthma introduces mesenchymal stem cells (MSCs) into the body via IV infusion to help reduce inflammation, regulate immune overactivity, and support tissue healing in the lungs.
This approach may benefit individuals with allergic, non-allergic, and treatment-resistant asthma who want to reduce reliance on medications and explore regenerative solutions.
Key Benefits of Stem Cell Treatment for Asthma
Stem cell treatment for asthma supports the body’s healing response and may improve long-term symptom control.
- May reduce airway inflammation and hyperresponsiveness
- Can improve breathing and lung function
- Non-surgical, outpatient IV infusion
- May reduce the need for inhalers, steroids, or biologics
- Supports immune modulation and respiratory repair
Many patients report improved breathing, fewer flare-ups, and enhanced quality of life after therapy.
We review your asthma history, current medications, and lung function tests to determine your eligibility for stem cell treatment.
Patients can begin remotely with a symptom review and medical history intake before traveling to Mexico.
Renova Therapies builds a personalized care plan for each patient based on asthma subtype, severity, and goals.
+1 888-471-3341
Our Value
Why Choose Stem Cell Treatment for Asthma in Mexico?
Common Questions
Frequently Asked Questions About Stem Cell Treatment for Asthma
Stem cell treatment for asthma is an innovative regenerative therapy that uses mesenchymal stem cells (MSCs) to reduce the chronic inflammation and immune hyperactivity that contribute to asthma symptoms. Asthma is often driven by inflammatory pathways that constrict airways, trigger mucus production, and lead to breathing difficulty. MSCs have unique immunomodulatory and anti-inflammatory properties that allow them to calm the overactive immune response, promote tissue repair in the bronchial lining, and improve overall lung function. This approach offers a more holistic, cellular-level intervention compared to medications that only mask symptoms or manage acute flare-ups.
The most common method of delivering stem cell therapy for asthma is through intravenous (IV) infusion. This approach allows the stem cells to circulate systemically and naturally home in on areas of inflammation and immune dysregulation, including the lungs and airway tissues. The procedure is performed in a comfortable outpatient setting and usually takes between 60 to 90 minutes. Patients are monitored throughout the process, and most are able to resume normal activities shortly afterward. In some advanced protocols, localized delivery methods may be explored, but IV infusion remains the safest and most widely used technique.
The timeline for improvement can vary from one patient to another, but many individuals begin to experience changes within the first 4 to 8 weeks. Early signs might include less frequent use of rescue inhalers, improved exercise tolerance, and reduced nighttime symptoms. As the body continues to respond to the regenerative effects of MSCs, more significant changes—including deeper breathing, fewer exacerbations, and greater lung function—often occur over the next 3 to 6 months. Continued progress may depend on the type of asthma, overall health, and how early the treatment is initiated.
While stem cell therapy is not designed to immediately replace conventional asthma medications, it may significantly reduce a patient’s dependency on them over time. Many patients report using fewer corticosteroids or rescue inhalers as their inflammation and immune reactivity diminish. This reduction can lead to fewer side effects from long-term medication use. However, it’s essential to consult with a primary care doctor or pulmonologist before making any changes to a medication regimen. In many cases, stem cell therapy is used alongside conventional treatment to gradually stabilize asthma control in a more sustainable way.
The cost of stem cell therapy for asthma at Renova Therapies generally ranges from $5,000 to $8,500 USD. This pricing reflects the number of stem cells used, the number of sessions required, and any additional supportive care provided. Packages typically include an initial medical evaluation, lab testing, stem cell processing, infusion, and post-treatment monitoring. For international patients, assistance with travel planning, hotel accommodations, and concierge services may also be available to ensure a smooth and comfortable treatment experience.
Patient safety is a top priority in all stem cell procedures at Renova Therapies. The MSCs used are rigorously tested for sterility, viability, and compatibility. These cells are ethically sourced, processed in certified laboratories, and administered under the supervision of experienced regenerative medicine physicians. The clinic adheres to international safety standards, and treatments are conducted in sterile, clinical environments. Most patients tolerate the infusion well, with side effects—if any—limited to mild fatigue or minor discomfort following treatment.
As of now, stem cell therapy for asthma is not approved by the U.S. Food and Drug Administration (FDA) for general clinical use. Ongoing research and clinical trials are evaluating its safety and efficacy, but regulatory approval is still pending. Due to these limitations, patients often travel to countries like Mexico where reputable clinics operate under legally regulated frameworks and provide access to proven regenerative protocols. Renova Therapies in Mexico offers one such option, combining expert care with transparent practices and a track record of success.
Potential candidates for stem cell therapy include adults diagnosed with moderate to severe chronic asthma who continue to experience symptoms despite conventional treatment. Patients with allergic asthma, occupational asthma, or mixed-type presentations may also benefit. Prior to therapy, a comprehensive screening process is conducted, including medical history review, lung function tests, blood work, and sometimes imaging. Patients with uncontrolled infections, cancer, or other serious comorbidities may be excluded for safety reasons. Ultimately, eligibility is determined through an in-depth consultation with the clinic’s medical team.
The effects of stem cell therapy can be long-lasting, particularly when supported by a healthy lifestyle, avoidance of environmental triggers, and ongoing medical follow-up. Some patients report stable respiratory improvements for several years following treatment. However, asthma is a chronic condition, and individual responses to therapy vary. In certain cases, follow-up treatments may be recommended after 12 to 24 months to maintain or enhance results. The need for additional sessions is usually based on clinical progress, changes in symptoms, and patient goals.
Many patients with allergic or immune-triggered asthma have found benefit from stem cell therapy, as mesenchymal stem cells are especially effective at calming overactive immune responses and reducing inflammation in the respiratory system. These cells have been shown to inhibit the production of pro-inflammatory cytokines and shift immune signaling toward a more balanced state. This mechanism makes them a potentially valuable option for those whose asthma is linked to environmental allergens, seasonal triggers, or immune hypersensitivity. However, ongoing allergen avoidance and other preventive measures should remain part of a comprehensive asthma care plan.